Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Smsbiotech Inc. operates a company patent portfolio in the Biotechnology & Pharmaceuticals technology area. The portfolio currently has 2 pending office actions. These actions are distributed among 2 distinct examiners and 2 distinct art units, reflecting a lack of concentration in the current examination phase.
KIM, TAEYOON is designated as the busiest examiner for this company. This examiner is responsible for 1 busiest examiner pending office action. Since the total number of pending office actions is 2, the remaining action is handled by the second of the 2 distinct examiners.
The use of 2 distinct art units suggests that the 2 pending office actions involve different technical classifications within the Biotechnology & Pharmaceuticals field. Practitioners should prepare for varied feedback, as the 2 distinct examiners may apply different standards or interpretations during the prosecution of these 2 pending office actions.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KIM, TAEYOON | 1 | 51.5% | +52.1% |
| TICHY, JENNIFER M.H. | 1 | 64.9% | +34.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17905851 | STEM CELL COMPOSITIONS AND METHODS OF REPAIRING TISSUE | KIM, TAEYOON | — |
| 17279408 | EXTRACELLULAR MATRIX PROTEIN COMPOSITIONS AND METHODS FOR TREATING WOUNDS | TICHY, JENNIFER M.H. | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17905851 | STEM CELL COMPOSITIONS AND METHODS OF REPAIRING TISSUE | KIM, TAEYOON | — |
| 17279408 | EXTRACELLULAR MATRIX PROTEIN COMPOSITIONS AND METHODS FOR TREATING WOUNDS | TICHY, JENNIFER M.H. | — |
| Art Unit | Apps |
|---|---|
| 1631 | 1 |
| 1653 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17905851 | STEM CELL COMPOSITIONS AND METHODS OF REPAIRING TISSUE | KIM, TAEYOON | 1631 | §103§112 | Non-Final OA | — | Pending | Sep 08, 2022 |
| 17279408 | EXTRACELLULAR MATRIX PROTEIN COMPOSITIONS AND METHODS FOR TREATING WOUNDS | TICHY, JENNIFER M.H. | 1653 | §103§112 | Final Rejection | — | Pending | Mar 24, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial